Bicocca Open Archive

Logo unimib boa
PIAZZA, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.557
AS - Asia 7.326
EU - Europa 7.186
SA - Sud America 1.013
Continente sconosciuto - Info sul continente non disponibili 865
AF - Africa 170
OC - Oceania 71
Totale 29.188
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.902
IT - Italia 2.489
SG - Singapore 2.073
CN - Cina 1.519
VN - Vietnam 1.464
HK - Hong Kong 802
DE - Germania 746
BR - Brasile 680
RU - Federazione Russa 630
SE - Svezia 532
CA - Canada 519
GB - Regno Unito 504
FR - Francia 418
IE - Irlanda 393
JP - Giappone 278
UA - Ucraina 271
BD - Bangladesh 234
ES - Italia 222
IN - India 204
NL - Olanda 204
FI - Finlandia 172
AT - Austria 135
TR - Turchia 133
KR - Corea 126
AR - Argentina 123
PL - Polonia 77
CH - Svizzera 76
BE - Belgio 71
MX - Messico 68
ID - Indonesia 67
AU - Australia 65
DK - Danimarca 64
CL - Cile 61
IQ - Iraq 59
TW - Taiwan 54
ZA - Sudafrica 43
EC - Ecuador 41
PK - Pakistan 39
PH - Filippine 36
PT - Portogallo 36
SA - Arabia Saudita 35
CO - Colombia 34
GR - Grecia 33
IR - Iran 32
VE - Venezuela 32
TH - Thailandia 24
MA - Marocco 21
UZ - Uzbekistan 21
NO - Norvegia 20
MY - Malesia 18
PE - Perù 18
AE - Emirati Arabi Uniti 17
TN - Tunisia 17
RE - Reunion 15
KE - Kenya 14
OM - Oman 14
PY - Paraguay 14
CR - Costa Rica 13
EG - Egitto 12
JM - Giamaica 11
SI - Slovenia 11
ET - Etiopia 10
LT - Lituania 10
RO - Romania 10
CZ - Repubblica Ceca 9
HN - Honduras 9
IL - Israele 9
JO - Giordania 9
LB - Libano 9
NP - Nepal 9
CI - Costa d'Avorio 8
DZ - Algeria 8
RS - Serbia 8
AL - Albania 6
AZ - Azerbaigian 6
BH - Bahrain 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PA - Panama 6
UY - Uruguay 6
BB - Barbados 5
BG - Bulgaria 5
BY - Bielorussia 5
EU - Europa 5
MT - Malta 5
SY - Repubblica araba siriana 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
LU - Lussemburgo 3
MD - Moldavia 3
MK - Macedonia 3
NI - Nicaragua 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 28.283
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.468
Ashburn 1.277
Singapore 1.251
Milan 830
Hong Kong 775
San Jose 759
Woodbridge 490
Ho Chi Minh City 448
Houston 371
Dublin 367
Hanoi 360
Frankfurt am Main 332
Chandler 309
Jacksonville 304
New York 302
Santa Clara 297
Wilmington 275
Toronto 263
Council Bluffs 240
Fairfield 228
Los Angeles 212
Dearborn 207
Rome 200
Chicago 197
Dallas 194
Beijing 174
Princeton 149
The Dalles 148
Hefei 144
Seattle 138
Nanjing 115
Columbus 112
Vienna 101
Cambridge 98
Munich 96
São Paulo 92
Seoul 88
Lauterbourg 86
Shanghai 83
Boardman 78
Buffalo 78
Helsinki 77
London 69
Tokyo 69
Moscow 65
Guangzhou 60
Atlanta 56
Lachine 56
Madrid 55
Sesto San Giovanni 55
Orem 51
Bologna 50
Barcelona 49
Denver 48
Da Nang 47
Amsterdam 45
Boston 44
Jakarta 44
Montreal 44
Santiago 44
Turin 43
Paris 42
Lawrence 39
Warsaw 39
Brooklyn 38
Naples 38
Dong Ket 37
Haiphong 37
Istanbul 37
Rio de Janeiro 37
Phoenix 36
Nanchang 34
Baghdad 33
San Diego 32
Altamura 31
Brussels 31
Florence 31
Washington 31
Figino 30
Shenyang 30
Berlin 29
Hải Dương 28
Bari 27
Boydton 27
Ha Long 27
Chennai 26
St Louis 26
Sydney 26
Jinan 25
Nuremberg 25
Philadelphia 25
Calgary 24
Chengdu 24
Croydon 24
Hangzhou 24
Hiroshima 24
Hyderabad 24
Ottawa 24
San Francisco 24
Andover 23
Totale 15.976
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization 3.439
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? 737
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 585
Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation 552
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 551
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 551
Feasibility of a standard cognitive assessment in European academic memory clinics 529
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 498
Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy 496
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 475
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 451
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 432
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 398
Iatrogenic CAA-ri supported by ARIA-E, raised CSF anti-Aβ autoantibodies and sTREM2 after COVID-19 vaccination 395
Biological markers of vascular damage in Alzheimer’s disease patients 389
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 379
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 369
Cerebral Amyloid Angiopathy-Related Inflammation 366
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 340
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 327
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 322
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 322
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 320
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 318
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 314
Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review 312
Ricerca quantitativa di Epstein-barr virus in campioni di liquor e sangue da pazienti affetti da sclerosi multipla 305
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 301
Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology 298
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study 294
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 290
Pathogenetic role of anti-AB autoantibodies in Cerebral Amyloid Angiopathy-related inflammation and Alzheimer's disease 283
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease 273
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy 272
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 272
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 268
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 268
Abrupt withdrawal of immunosuppressive drugs: a potential trigger for CAA-ri 262
Ubiquitin regulates GGA3-mediated degradation of BACE1 258
A challenging diagnosis of reversible “vascular” dementia: Cerebral amyloid angiopathy-related inflammation 254
Microbiota-gut-brain axis dysregulation in Alzheimer’s disease and its modulation through probiotic supplementation 252
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 252
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 246
Anti-Aβ autoantibodies in CAA-ri vs AD patients: different singers for the same ARIA? 245
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 240
CSF biomarkers for Amyloid Related Imaging Abnormalities (ARIA) in immunotherapy trials of Alzheimer’s disease and Cerebral Amyloid Angiopathy: report from the iCAß International Network 239
Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease 236
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 236
Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease 233
Anti-abeta antibodies in CSF: markers for therapies? 228
Analytical Validation of a pre-Industrial Prototype Assay for Anti-Aβ Autoantibody ultrasensitive quantification in patients with CAA-ri and ARIA-E of Alzheimer’s disease Immunotherapy 225
BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus. 220
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 220
Biomarkers in cerebral amyloid angiopathy-related inflammation 219
Metodo e kit per la rilevazione di anticorpi 214
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 212
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease 211
Author Response: Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 209
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 207
Increased levels of tissue factor pathway inhibitor in cerebrospinal fluid are related to neurodegeneration in alzheimer’s disease patients 206
Pathogenetic similarities shared by Alzheimer's disease and multiple sclerosis 201
Effect of TNF-alpha on platelet glutamate uptake in Stroke patients 201
Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy? 198
CSF anti-Aß autoantibodies as novel biomarker for Cerebral Amyloid Angiopathy-related inflammation: implications for amyloid-related imaging abnormalities (ARIA) during passive immunization in Alzheimer’s disease 195
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 194
Platelets might mediate the increase of plasma glutamate in acute ischemic stroke: Relevance for early neurological deterioration 190
Symposium Immunotherapy Trials in CAA and AD: The ARIA paradox in AD and CAA: merely an adverse event or an out of tune proof of immunotherapy effectiveness? 186
Autologous anti-Aß antibodies in caa-ri: new biomarker for detection of Amyloid-Related Imaging Abnormalities (ARIA) during Aß-disease modifying therapies for AD 185
Pathogenetic Role of Anti- Aß Autoantibodies in CAA-related Inflammation: Implications for Amyloid-modifying Therapies in AD 184
Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case 183
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 182
CAA-ri and ARIA: Two Faces of the Same Coin? 178
Anti-Aß autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease βiomarkers Collaborative Network (iCAβ) 177
Inflammatory CAA and AD Biomarkers International Network 174
Non-vascular leucoencephalic dementia: The case of Cerebral Amyloid Angiopathy related inflammation 174
A method and a kit for the detection of anti-beta amyloid antibodies 174
Anti-Amyloid Treatments: A Therapeutic Revolution, Ready for Europe 173
Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice 172
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 170
Auto-antibodies to Aß in CSF 170
Cerebral amyloid angiopathy-related inflammation. report of a case 170
Large Collaborative Registries and Real-World Data to Manage Amyloid-Related Imaging Abnormalities 170
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model 163
The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue 161
Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies 159
Vascular damage and neurodegeneration 159
Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) 158
Cerebrospinal Fluid Anti-Amyloid-Beta; Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation 157
Données récentes sur l’Amyloïdose Cérébrale Inflammatoire. 152
Why does ARIA‐E appear bright? A quantitative model linking brain tissue composition and T2 FLAIR hyperintensities 150
Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services 147
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 144
Anti-Aß autoantibodies and endothelial damage during spontaneous Amyloid-Related Imaging Abnormalities (ARIA): report from the inflammatory cerebral amyloid angiopathy and alzheimer's disease biomarkers collaborative network (iCAB) 143
The inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease Biomarkers International Network (iCAβ) initiative 138
Inflammatory CAA mechanisms and biomarkers– lessons for sporadic CAA diagnosis and treatment 134
Spontaneous and Drug-Induced Amyloid-Related Imaging Abnormalities: Overlaps, Divergences, and Clinical Implications Across a Continuum Between Alzheimer’s Disease and Cerebral Amyloid Angiopathy 132
Abstract W MP89: Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 120
Iatrogenic cerebral amyloid angiopathy and cerebral amyloid angiopathy-related inflammation: clinical, radiological and biological findings from a case 102
The Inflammatory Side of Iatrogenic Cerebral Amyloid Angiopathy: Rethinking Therapeutic Opportunities 90
Mechanisms of Dural Involvement in Cerebral Amyloid Angiopathy 84
Totale 29.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.150
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022743 0 0 0 97 74 106 33 31 42 76 74 210
2022/20231.727 204 419 146 146 147 232 96 91 172 16 37 21
2023/20241.316 44 67 59 62 180 274 229 82 133 32 39 115
2024/20253.696 164 421 317 135 297 179 277 202 382 463 291 568
2025/202612.138 1.434 862 773 1.136 1.207 791 1.452 747 1.066 943 703 1.024
2026/20273.871 604 1.056 1.350 861 0 0 0 0 0 0 0 0
Totale 29.188